Literature DB >> 18097183

Nerve growth factor helps protect retina in experimental retinal detachment.

Xiaodong Sun1, Xun Xu, Fenghua Wang, Xi Zhang, Patrick C P Ho, Haiyang Liu, Jin Qian, Zhang Yu, Hongfen Lu, Weiqi Xu.   

Abstract

PURPOSE: To investigate the expression of nerve growth factor (NGF) and its receptor TrkA on the retina at different time points after retinal detachment (RD) and the protection effect of NGF in experimental RD.
METHODS: Sprague-Dawley rats were used as an RD animal model by injection of 0.1% sodium hyaluronate under the neurosensory retina. The expression of endogenous NGF and its receptor TrkA in the rat retina was detected using immunohistochemistry. The NGF (5 mug/eye) or phosphate-buffered saline were injected separately into vitreous every 4 days after the RD. The rat eyes were then observed at various time points. Morphologic changes were investigated by light microscopy. Retinal gliosis was detected by glial fibrillary acidic protein labeling.
RESULTS: The expression of endogenous NGF and TrkA was upregulated during RD procedure. Most of the NGF-treated retina had a well-organized structure. In NGF-treated RD eyes, the cells were still significantly more numerous than in phosphate-buffered-saline-treated retina. Glial fibrillary acidic protein labeling increased quickly after RD; the NGF-treated retina had less reactive gliosis than the control groups.
CONCLUSIONS: Intravitreal injection of exogenous NGF can protect retinal cells from degeneration in experimental RD. It may exert its protective action by preventing the apoptosis of retinal cells after RD. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18097183     DOI: 10.1159/000109281

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  7 in total

1.  Activation of autophagy in photoreceptor necroptosis after experimental retinal detachment.

Authors:  Kai Dong; Zi-Cheng Zhu; Feng-Hua Wang; Gen-Jie Ke; Zhang Yu; Xun Xu
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

2.  Upregulation of Semaphorin 3A and the associated biochemical and cellular events in a rat model of retinal detachment.

Authors:  Olga Klebanov; Anat Nitzan; Dorit Raz; Ari Barzilai; Arieh S Solomon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-25       Impact factor: 3.117

3.  Neural Mobilization Treatment Decreases Glial Cells and Brain-Derived Neurotrophic Factor Expression in the Central Nervous System in Rats with Neuropathic Pain Induced by CCI in Rats.

Authors:  Aline Carolina Giardini; Fabio Martinez Dos Santos; Joyce Teixeira da Silva; Mara Evany de Oliveira; Daniel Oliveira Martins; Marucia Chacur
Journal:  Pain Res Manag       Date:  2017-03-22       Impact factor: 3.037

4.  Intravitreal NGF administration counteracts retina degeneration after permanent carotid artery occlusion in rat.

Authors:  Sandra Sivilia; Alessandro Giuliani; Mercedes Fernández; Maria Elena Turba; Monica Forni; Alessandro Massella; Nadia De Sordi; Luciana Giardino; Laura Calzà
Journal:  BMC Neurosci       Date:  2009-05-27       Impact factor: 3.288

5.  Effects of BNN27, a novel C17-spiroepoxy steroid derivative, on experimental retinal detachment-induced photoreceptor cell death.

Authors:  Pavlina Tsoka; Hidetaka Matsumoto; Daniel E Maidana; Keiko Kataoka; Irene Naoumidi; Achille Gravanis; Demetrios G Vavvas; Miltiadis K Tsilimbaris
Journal:  Sci Rep       Date:  2018-07-13       Impact factor: 4.379

6.  Internal limiting membrane insertion technique combined with nerve growth factor injection for large macular hole.

Authors:  Luyi Zhang; Xiaoxia Li; Xiaoli Yang; Yu Shen; Miaoqin Wu
Journal:  BMC Ophthalmol       Date:  2019-12-10       Impact factor: 2.209

7.  Intravitreal Administration of rhNGF Enhances Regenerative Processes in a Zebrafish Model of Retinal Degeneration.

Authors:  Pasquale Cocchiaro; Vincenzo Di Donato; Davide Rubbini; Rodolfo Mastropasqua; Marcello Allegretti; Flavio Mantelli; Andrea Aramini; Laura Brandolini
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.